Jenburkt Pharmaceuticals has informed that the Company has decided in pursuance of the Company's Prohibition of Insider Trading Code 2015, the trading window will remain closed for all the trades by the Insider on the exchange from 18th May, 2018 till 48 hours of dissemination or making public the price sensitive information.
The above information is a part of company’s filings submitted to BSE.